Medifron DBT Co. Ltd (065650) — Financial Flexibility Index
Medifron DBT Co. Ltd (065650) has a Financial Flexibility Index of -0.14x as of September 2025. Free cash flow of ₩-12.54 Billion (operating CF ₩-12.73 Billion minus capex ₩198.12 Million) represents 0% of total liabilities (₩86.61 Billion). Check Medifron DBT Co. Ltd (065650) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Medifron DBT Co. Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Medifron DBT Co. Ltd across 11 annual periods. See working capital to net assets of Medifron DBT Co. Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Medifron DBT Co. Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Medifron DBT Co. Ltd. For the full company profile including market capitalisation, see 065650 market cap.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.05x | ₩-1.94 Billion | ₩-4.54 Billion | ₩42.92 Billion | ▲ +52.2% |
| 2023 | -0.09x | ₩-1.79 Billion | ₩-2.14 Billion | ₩18.89 Billion | ▼ -46.9% |
| 2022 | -0.06x | ₩-1.59 Billion | ₩-2.91 Billion | ₩24.66 Billion | ▼ -127.0% |
| 2021 | 0.24x | ₩1.62 Billion | ₩-1.50 Billion | ₩6.81 Billion | ▲ +628.7% |
| 2020 | -0.05x | ₩-874.06 Million | ₩-1.67 Billion | ₩19.36 Billion | ▲ +98.1% |
| 2019 | -2.39x | ₩-4.23 Billion | ₩-4.28 Billion | ₩1.77 Billion | ▼ -580.5% |
| 2018 | -0.35x | ₩-832.97 Million | ₩-852.48 Million | ₩2.37 Billion | ▲ +54.5% |
| 2017 | -0.77x | ₩-1.15 Billion | ₩-1.17 Billion | ₩1.49 Billion | ▼ -49.2% |
| 2016 | -0.52x | ₩-1.13 Billion | ₩-1.15 Billion | ₩2.18 Billion | ▼ -2436.0% |
| 2015 | -0.02x | ₩-143.36 Million | ₩-170.27 Million | ₩7.04 Billion | ▼ -213.6% |
| 2014 | 0.02x | ₩27.61 Million | ₩701.96K | ₩1.54 Billion | — |